Shizuoka, Japan

Tetsuo Kojima

This inventor holds 17 USPTO granted patents and 41 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Peptide Therapeutics. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Chugai Suyaku K.k., Fuji Photo Film Company, Limited. Active years: 1990-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuo Kojima. Retrieved from https://idiyas.com/inventor/tetsuo-kojima-q4rj5agb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 82.4


 

Average Co-Inventor Count = 3.2

ph-index = 11

Forward Citations = 423(Granted Patents)


Location History:

  • Niihari-mura, JP (2005)
  • Shizuoka, JP (1998 - 2020)
  • Kanagawa, JP (1990 - 2024)

Company Filing History:


Years Active: 1990-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Peptide-Cyclization
Bispecific Antibodies
IL-6 Activity
Cell-Free Translation
Antibody Production
ScDb Libraries
Signaling Peptides
Cellular Assays
Antibody Light Chains
Haemopoietin Receptor
Megakaryocyte Potentiator
Photographic Material
17 patents (USPTO):Explore Patents

Title: Tetsuo Kojima: Innovator in Peptide Synthesis

Introduction

Tetsuo Kojima is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of peptide synthesis, holding a total of 17 patents. His work focuses on developing novel methods for drug discovery and peptide synthesis, which have the potential to revolutionize the pharmaceutical industry.

Latest Patents

One of his latest patents is a peptide-compound cyclization method. The objective of this invention is to provide methods for discovering drugs that are effective for challenging targets, which have traditionally been difficult to identify. This invention relates to innovative methods for cyclizing peptide compounds, as well as novel peptide compounds and libraries that comprise these compounds. Another significant patent is for a method of synthesizing peptides in a cell-free translation system. This invention aims to synthesize peptides containing structurally diverse amino acids using cell-free translation systems, achieving superior translational efficiency compared to conventional techniques. The method involves protecting an amino acid linked to tRNA with an appropriate protecting group and performing the deprotection and peptide translation steps in parallel.

Career Highlights

Throughout his career, Tetsuo Kojima has worked with notable companies, including Chugai Seiyaku Kabushiki Kaisha and Chugai Suyaku K.K. His experience in these organizations has contributed to his expertise in peptide synthesis and drug discovery.

Collaborations

Tetsuo Kojima has collaborated with several professionals in his field, including Tomoyuki Igawa and Atsushi Ohta. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in peptide synthesis.

Conclusion

Tetsuo Kojima is a distinguished inventor whose work in peptide synthesis and drug discovery has made a significant impact in the field. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and improving pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…